A novel mutation of the human 7-dehydrocholesterol reductase gene reduces enzyme activity in patients with holoprosencephaly

Yhong Hee Shim, Soo Han Bae, Jai Hyun Kim, Kyu Rae Kim, Chong Jai Kim, Young-Ki Paik

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Defects in cholesterol biosynthesis genes are recognized as a leading cause for holoprosencephaly (HPE). Previous reports suggest that mutations of human 7-dehydrocholesterol reductase (Dhcr7), which catalyzes the final step of cholesterol biosynthesis, may cause HPE [Clin. Genet. 53 (1998) 155]. To determine whether Dhcr7 mutations are involved in HPE pathogenesis, we analyzed the sequence of exon 9, which contains both a catalytic domain and a mutational hot spot. We examined 36 prematurely terminated fetuses with HPE at their gestation ages in the range from 21 to 33 weeks by single strand conformation polymorphism analysis and DNA sequencing. A novel missense mutation was identified: G344D. Dhcr7 enzyme assays using overexpressed recombinant mutant proteins revealed altered enzyme activity. Mutant G344D harbored less than 50% of enzyme activity compared with the control. Two previously reported mutations, R404C and G410S, abolished enzyme activity. These results suggest that mutation of the Dhcr7 gene is involved in HPE pathogenesis.

Original languageEnglish
Pages (from-to)219-223
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume315
Issue number1
DOIs
Publication statusPublished - 2004 Feb 27

Fingerprint

Holoprosencephaly
Enzyme activity
Genes
Biosynthesis
Mutation
Enzymes
Cholesterol
Recombinant proteins
Mutant Proteins
Polymorphism
Conformations
Exons
Assays
Viverridae
Enzyme Assays
Missense Mutation
Defects
DNA Sequence Analysis
Recombinant Proteins
DNA

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

@article{82b2a06ff34243ca9ec9b59f6a6a29f3,
title = "A novel mutation of the human 7-dehydrocholesterol reductase gene reduces enzyme activity in patients with holoprosencephaly",
abstract = "Defects in cholesterol biosynthesis genes are recognized as a leading cause for holoprosencephaly (HPE). Previous reports suggest that mutations of human 7-dehydrocholesterol reductase (Dhcr7), which catalyzes the final step of cholesterol biosynthesis, may cause HPE [Clin. Genet. 53 (1998) 155]. To determine whether Dhcr7 mutations are involved in HPE pathogenesis, we analyzed the sequence of exon 9, which contains both a catalytic domain and a mutational hot spot. We examined 36 prematurely terminated fetuses with HPE at their gestation ages in the range from 21 to 33 weeks by single strand conformation polymorphism analysis and DNA sequencing. A novel missense mutation was identified: G344D. Dhcr7 enzyme assays using overexpressed recombinant mutant proteins revealed altered enzyme activity. Mutant G344D harbored less than 50{\%} of enzyme activity compared with the control. Two previously reported mutations, R404C and G410S, abolished enzyme activity. These results suggest that mutation of the Dhcr7 gene is involved in HPE pathogenesis.",
author = "Shim, {Yhong Hee} and Bae, {Soo Han} and Kim, {Jai Hyun} and Kim, {Kyu Rae} and Kim, {Chong Jai} and Young-Ki Paik",
year = "2004",
month = "2",
day = "27",
doi = "10.1016/j.bbrc.2004.01.041",
language = "English",
volume = "315",
pages = "219--223",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

A novel mutation of the human 7-dehydrocholesterol reductase gene reduces enzyme activity in patients with holoprosencephaly. / Shim, Yhong Hee; Bae, Soo Han; Kim, Jai Hyun; Kim, Kyu Rae; Kim, Chong Jai; Paik, Young-Ki.

In: Biochemical and Biophysical Research Communications, Vol. 315, No. 1, 27.02.2004, p. 219-223.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A novel mutation of the human 7-dehydrocholesterol reductase gene reduces enzyme activity in patients with holoprosencephaly

AU - Shim, Yhong Hee

AU - Bae, Soo Han

AU - Kim, Jai Hyun

AU - Kim, Kyu Rae

AU - Kim, Chong Jai

AU - Paik, Young-Ki

PY - 2004/2/27

Y1 - 2004/2/27

N2 - Defects in cholesterol biosynthesis genes are recognized as a leading cause for holoprosencephaly (HPE). Previous reports suggest that mutations of human 7-dehydrocholesterol reductase (Dhcr7), which catalyzes the final step of cholesterol biosynthesis, may cause HPE [Clin. Genet. 53 (1998) 155]. To determine whether Dhcr7 mutations are involved in HPE pathogenesis, we analyzed the sequence of exon 9, which contains both a catalytic domain and a mutational hot spot. We examined 36 prematurely terminated fetuses with HPE at their gestation ages in the range from 21 to 33 weeks by single strand conformation polymorphism analysis and DNA sequencing. A novel missense mutation was identified: G344D. Dhcr7 enzyme assays using overexpressed recombinant mutant proteins revealed altered enzyme activity. Mutant G344D harbored less than 50% of enzyme activity compared with the control. Two previously reported mutations, R404C and G410S, abolished enzyme activity. These results suggest that mutation of the Dhcr7 gene is involved in HPE pathogenesis.

AB - Defects in cholesterol biosynthesis genes are recognized as a leading cause for holoprosencephaly (HPE). Previous reports suggest that mutations of human 7-dehydrocholesterol reductase (Dhcr7), which catalyzes the final step of cholesterol biosynthesis, may cause HPE [Clin. Genet. 53 (1998) 155]. To determine whether Dhcr7 mutations are involved in HPE pathogenesis, we analyzed the sequence of exon 9, which contains both a catalytic domain and a mutational hot spot. We examined 36 prematurely terminated fetuses with HPE at their gestation ages in the range from 21 to 33 weeks by single strand conformation polymorphism analysis and DNA sequencing. A novel missense mutation was identified: G344D. Dhcr7 enzyme assays using overexpressed recombinant mutant proteins revealed altered enzyme activity. Mutant G344D harbored less than 50% of enzyme activity compared with the control. Two previously reported mutations, R404C and G410S, abolished enzyme activity. These results suggest that mutation of the Dhcr7 gene is involved in HPE pathogenesis.

UR - http://www.scopus.com/inward/record.url?scp=0842329643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0842329643&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2004.01.041

DO - 10.1016/j.bbrc.2004.01.041

M3 - Article

C2 - 15013448

AN - SCOPUS:0842329643

VL - 315

SP - 219

EP - 223

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -